ABSTRACT
Infections of the urinary tract occur quite frequently in patients of both sex in the practice as well as in the hospital. They are caused mainly by bacteria. However, virus- and significant fungus-infections of the kidney and the urinary tract are observed due to acquired immuno-suppression or induced by the physician. The current knowledge about this problem is still insufficient. Obtaining a careful history, the physical examination and biochemical analysis are still of great value for a successful treatment. Besides the drug therapy, the physiological immunological mechanisms should be activated by unspecific procedures. If they are the only risk factor, urinary tract infections including chronic courses never lead to kidney failure necessitating a dialysis.
Subject(s)
Urinary Tract Infections/etiology , Adolescent , Adult , Anti-Infective Agents, Urinary/therapeutic use , Bacteriuria/diagnosis , Bacteriuria/etiology , Bacteriuria/therapy , Child , Child, Preschool , Female , Humans , Male , Microbial Sensitivity Tests , Pregnancy , Urinary Tract Infections/diagnosis , Urinary Tract Infections/therapyABSTRACT
In this study we evaluated the effect of a daily administration of 1 g salmon-oil concentrate containing 0.2 g eicosapentaenoic acid (EPA) on the blood pressure, serum cholesterol, HDL and LDL cholesterol, triglycerides and magnesium of ten patients on chronic haemodialysis. Systolic and diastolic blood pressure values decreased significantly from 156 +/- 27.7/84 +/- 14.3 to 140 +/- 22.8/75.6 +/- 8.21 mmHg. Concordantly, mean arterial pressure (MAP) decreased significantly from 108 to 96 mmHg. Total serum cholesterol decreased significantly by 64%, HDL cholesterol increased by 47% (P less than 0.001). Serum triglyceride values decreased significantly to 48%. There was a distinct decline of magnesium from 1.42 +/- 0.27 to 1.28 +/- 0.13 mg/dl (P less than 0.001). According to these results, the administration of omega-3 fatty acids may be considered as a reasonable approach in the treatment of dyslipoproteinaemia in patients on continuous haemodialysis.